EUVIMEDEUVIMED entdecken
Fallbericht

Rectus Sheath Hematoma in a Patient with Dual-Antiplatelet Therapy Including Ticagrelor: A Case Report

Sinan Genç, Ahmet Sefa Yeter, Ahmet Burak Oğuz, Ayça Koca, Onur Polat, Müge Günalp Eneyli

Hämostaseologie · 2023-06 · 43 (03) · 219-221

DOI: 10.1055/a-2020-4643 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Hämostaseologie, online erschienen am 19.05.2023. Verfasst von Sinan Genç und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Ankara University Faculty of Medicine, Ankara, Turkey. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 12 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rectus sheath hematoma (RSH) is an uncommon cause of abdominal pain associated with several risk factors including trauma, asthma, chronic obstructive pulmonary disease, pregnancy, and anticoagulation as it can be iatrogenic. Dual-antiplatelet therapy (DAPT), combined usage of a P2Y12 receptor inhibitor and aspirin, is a cornerstone treatment for patients with acute coronary syndromes. Ticagrelor is a P2Y12 receptor inhibitor with several adverse hemorrhagic complications. An 86-year-old male patient was admitted to the emergency department with abdominal pain and a palpable abdominal mass at the left upper quadrant of the abdomen. His medical history revealed coronary artery disease with medications including acetylsalicylic acid and ticagrelor. Contrast-enhanced abdominal computed tomography revealed RSH. The patient was treated conservatively with bed rest and analgesia. DAPT is an essential component of the management of acute coronary syndromes to prevent recurrent cardiac thrombotic events. However, hemorrhagic complications such as RSH may be encountered with DAPT. Emergency medicine physicians and cardiologists should keep in mind RSH in patients presenting with abdominal pain and using DAPT with ticagrelor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Coronary SyndromePercutaneous Coronary InterventionMaleHumansAged, 80 and overTicagrelorPlatelet Aggregation InhibitorsAspirinHematomaAbdominal Pain

Substanzen

TicagrelorPlatelet Aggregation InhibitorsAspirin

Autor:innen und Institutionen

  • Department of Emergency Medicine, Ankara University Faculty of Medicine, Ankara, Turkey.
  • Emergency Service, Ankara Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkey.

Zitieren

APA

Genç, S., Yeter, A. S., Oğuz, A. B., Koca, A., Polat, O., & Günalp Eneyli, M. (2023). Rectus Sheath Hematoma in a Patient with Dual-Antiplatelet Therapy Including Ticagrelor: A Case Report. Hämostaseologie, 43(03), 219-221. https://doi.org/10.1055/a-2020-4643

Vancouver

Genç S, Yeter AS, Oğuz AB, Koca A, Polat O, Günalp Eneyli M. Rectus Sheath Hematoma in a Patient with Dual-Antiplatelet Therapy Including Ticagrelor: A Case Report. Hämostaseologie. 2023;43(03):219-221. doi:10.1055/a-2020-4643

BibTeX
@article{Gen2023,
  author = {Genç, Sinan and Yeter, Ahmet Sefa and Oğuz, Ahmet Burak and Koca, Ayça and Polat, Onur and Günalp Eneyli, Müge},
  title = {Rectus Sheath Hematoma in a Patient with Dual-Antiplatelet Therapy Including Ticagrelor: A Case Report},
  journal = {Hämostaseologie},
  year = {2023},
  volume = {43},
  number = {03},
  pages = {219--221},
  doi = {10.1055/a-2020-4643}
}
Kostenlos starten →